Glaukos Corporation (GKOS)
NYSE: GKOS · Real-Time Price · USD
108.51
-0.34 (-0.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
Glaukos Employees
Glaukos had 995 employees as of December 31, 2024. The number of employees increased by 88 or 9.70% compared to the previous year.
Employees
995
Change (1Y)
88
Growth (1Y)
9.70%
Revenue / Employee
$472,181
Profits / Employee
-$88,054
Market Cap
6.23B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GKOS News
- 3 days ago - Glaukos Corporation (GKOS) Presents at Citi Annual Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 25 days ago - Glaukos Corporation (GKOS) Presents at UBS Global Healthcare Conference 2025 Transcript - Seeking Alpha
- 4 weeks ago - Brown Capital Sells $35 Million in Glaukos Stock After Sharp Sell-Off - The Motley Fool
- 4 weeks ago - Glaukos Announces Participation in Upcoming Investor Conferences - Business Wire
- 5 weeks ago - Why Glaukos Stock Zoomed Almost 14% Higher on Thursday - The Motley Fool
- 5 weeks ago - Glaukos Corporation (GKOS) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Glaukos Announces Third Quarter 2025 Financial Results - Business Wire
- 6 weeks ago - US FDA approves Glaukos' new eye therapy - Reuters